REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 64 filers reported holding REPROS THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,000 | -37.5% | 3,757 | 0.0% | 0.00% | – |
| Q3 2016 | $8,000 | +14.3% | 3,757 | -13.1% | 0.00% | – |
| Q2 2016 | $7,000 | +75.0% | 4,324 | 0.0% | 0.00% | – |
| Q1 2016 | $4,000 | -20.0% | 4,324 | 0.0% | 0.00% | – |
| Q4 2015 | $5,000 | -83.9% | 4,324 | +2.8% | 0.00% | – |
| Q3 2015 | $31,000 | +6.9% | 4,208 | +5.2% | 0.00% | – |
| Q2 2015 | $29,000 | -95.2% | 4,001 | -94.4% | 0.00% | -100.0% |
| Q1 2015 | $609,000 | -12.9% | 70,862 | +1.0% | 0.00% | 0.0% |
| Q4 2014 | $699,000 | +3.6% | 70,146 | +2.8% | 0.00% | 0.0% |
| Q3 2014 | $675,000 | -42.3% | 68,211 | +0.9% | 0.00% | -50.0% |
| Q2 2014 | $1,169,000 | +3.5% | 67,576 | +6.1% | 0.00% | 0.0% |
| Q1 2014 | $1,130,000 | -1.7% | 63,692 | +1.4% | 0.00% | 0.0% |
| Q4 2013 | $1,150,000 | -33.0% | 62,838 | -1.9% | 0.00% | -33.3% |
| Q3 2013 | $1,717,000 | +86.4% | 64,069 | +28.3% | 0.00% | +50.0% |
| Q2 2013 | $921,000 | – | 49,941 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,001,000 | $970,000 | 0.21% |
| Allegis Investment Advisors, LLC | 341,669 | $331,000 | 0.19% |
| GENERAL AMERICAN INVESTORS CO INC | 396,123 | $384,000 | 0.04% |
| Alambic Investment Management, L.P. | 114,591 | $111,000 | 0.04% |
| Gruss Capital Management LP | 600,000 | $582,000 | 0.02% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 102,086 | $99,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 323,429 | $314,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 27,931 | $27,000 | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 2,700 | $3,000 | 0.00% |
| Airain ltd | 13,690 | $13,000 | 0.00% |